about
Analysis of binding sites on complement factor I that are required for its activityGenetic, molecular and functional analyses of complement factor I deficiencySpecific inhibition of the classical complement pathway by C1q-binding peptides.Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis.C4b-binding protein is present in affected areas of myocardial infarction during the acute inflammatory phase and covers a larger area than C3.A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndromeThe prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical.Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis.Autoantibodies to complement components.Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage.Complement and renal disease.Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis.Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study.Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis.An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis.Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.Role of complement and complement regulators in the removal of apoptotic cells.Complement activation and inhibition: a delicate balance.Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes.Role of complement in innate immunity and host defense.Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis.Complement activation by (auto-) antibodies.The influence of ACPA status and characteristics on the course of RA.Autoantibodies against complement components and functional consequences.Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies.Biomarkers for rheumatoid and psoriatic arthritis.C1q, antibodies and anti-C1q autoantibodies.The complement system as a potential therapeutic target in rheumatic disease.Short article: Absence of serological rheumatoid arthritis biomarkers in inflammatory bowel disease patients with arthropathies.Breach of autoreactive B cell tolerance by post-translationally modified proteins.Type I Interferon Gene Response Is Increased in Early and Established Rheumatoid Arthritis and Correlates with Autoantibody Production.Production of complement components by cells of the immune system.Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands.Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.
P50
Q24645042-710A2408-727C-4377-9501-7693CAF2B980Q28303343-00D738ED-F4B2-45A7-B964-3841D690FC67Q30776720-103F498F-4201-47A7-BD43-63447DA4B23FQ33340963-D16CF645-7227-4EEA-A42E-EF699E6799FCQ33358146-F3072CBB-6593-49A8-87D5-51581056FE95Q33373174-63EAA823-B454-406F-847D-15C717443776Q33402827-9278F3FC-E25F-46BA-97D3-FF4BB9832B42Q33750031-79F06E13-1080-4DDF-A0D3-BD0843E70EFCQ33904381-3A24BE8F-B523-4F6E-898F-65BC5C65F55AQ34353033-88A7F525-635B-4369-97E6-13E16ADB1E18Q35149378-D22DD052-E0A7-4CD2-95F7-7E21CE9876ACQ35197933-28E8A5C9-0D6D-4E64-AF91-075E5B48C572Q35251912-1FDB62AB-C5FA-45D3-8AF5-E7179EB53F0EQ35408694-09D60A70-74D3-4856-B5AB-A24C5E5FB174Q35562029-8D23C604-F6C5-4BD0-A98F-1F893C3503D2Q35834431-5CA83251-2045-486D-B420-5883065F178CQ35994186-5DA3E352-F1B1-4893-8F16-01B96A0A9DA5Q36127049-784481A6-3C97-41AC-8C54-A119BCA1E1B7Q36565997-CD9439A8-C314-4AE4-9A53-4623098D283EQ36968730-27F0EF87-3B72-4690-B941-6D72DF482CDDQ36981893-5EC5065D-7B2B-4F1E-B3E9-A88FCB867369Q37368654-CEBFF983-5116-4C00-8FFB-0F12572D1718Q37470470-410D7C18-ED0B-496A-A596-7422A15037F8Q37486571-28CC4FA9-4CF9-49B4-A58D-7B8DE4C9D4BDQ37844781-54619E9F-843B-48EF-9024-2878F80D39A3Q37898025-A8E86AEE-2617-4C5E-A111-D891B42D5324Q37901199-521D9D08-8299-4B59-84B0-BF68A56AC62AQ37980340-EBCA54F1-74E4-4FD0-8642-304CEF882992Q38116172-840896F1-9F8B-4680-BFCF-2098CF8D763FQ38157376-315D69D9-DC6A-46B2-8C7F-C1F8AE64CE0BQ38454424-08B40521-3457-412D-834E-1CF285CAE1A5Q38511260-AEA8F68E-58A1-4DC2-BC1A-670BB63E30B0Q38631542-1C12DD78-F30D-4665-9C05-277552CA0DB5Q38786106-C0ED82F0-65FD-4978-8D1C-06E3971A17CBQ38820148-3E91A5CD-A730-41F3-ADE5-41E7563A1030Q38857308-5F971110-9FA5-48B8-85D5-7F951FED8B5BQ38935414-960F8B60-63CF-442F-838B-9B73BF938480Q39043798-33F0D2FF-8639-41B9-99DC-0A6E0F8A0479Q39139958-F40486FD-4B73-4792-AE78-88FE3596D2DEQ39169435-66DDC131-09AD-435B-94FC-2F9FC11B023F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Leendert A Trouw
@ast
Leendert A Trouw
@en
Leendert A Trouw
@es
Leendert A Trouw
@nl
Leendert A Trouw
@sl
type
label
Leendert A Trouw
@ast
Leendert A Trouw
@en
Leendert A Trouw
@es
Leendert A Trouw
@nl
Leendert A Trouw
@sl
prefLabel
Leendert A Trouw
@ast
Leendert A Trouw
@en
Leendert A Trouw
@es
Leendert A Trouw
@nl
Leendert A Trouw
@sl
P106
P21
P31
P496
0000-0001-5186-2290
P569
2000-01-01T00:00:00Z